# FDA Inspection 1073644 - Bloodworks - October 26, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/bloodworks/9348b18b-7a54-412d-b3da-f9182702f429
Source feed: FDA_Inspections

> FDA Inspection 1073644 for Bloodworks on October 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073644
- Company Name: Bloodworks
- Inspection Date: 2018-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1223915 - 2023-11-29](https://www.globalkeysolutions.net/records/fda_inspections/bloodworks/d6b1dd99-1711-434b-b8ca-72017bc6c67c)
- [FDA Inspection 988680 - 2016-10-19](https://www.globalkeysolutions.net/records/fda_inspections/bloodworks/4516b859-0631-4aeb-b00c-1a82ed61803e)
- [FDA Inspection 899880 - 2014-10-15](https://www.globalkeysolutions.net/records/fda_inspections/bloodworks/ff652539-b4b6-44e1-a791-a773e5ee0fed)

Company: https://www.globalkeysolutions.net/companies/bloodworks/b3a1425b-e119-4c73-a273-a6b74ef813a9

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d